rs387906409

Variant summary

Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM2PP3_StrongPP5_Moderate

The NM_001609.4(ACADSB):​c.1228G>A​(p.Gly410Ser) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000907 in 1,544,128 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★).

Frequency

Genomes: 𝑓 0.000011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000089 ( 0 hom. )

Consequence

ACADSB
NM_001609.4 missense, splice_region

Scores

10
5
4
Splicing: ADA: 1.000
2

Clinical Significance

Pathogenic criteria provided, single submitter P:2

Conservation

PhyloP100: 9.97
Variant links:
Genes affected
ACADSB (HGNC:91): (acyl-CoA dehydrogenase short/branched chain) Short/branched chain acyl-CoA dehydrogenase(ACADSB) is a member of the acyl-CoA dehydrogenase family of enzymes that catalyze the dehydrogenation of acyl-CoA derivatives in the metabolism of fatty acids or branch chained amino acids. Substrate specificity is the primary characteristic used to define members of this gene family. The ACADSB gene product has the greatest activity towards the short branched chain acyl-CoA derivative, (S)-2-methylbutyryl-CoA, but also reacts significantly with other 2-methyl branched chain substrates and with short straight chain acyl-CoAs. The cDNA encodes for a mitochondrial precursor protein which is cleaved upon mitochondrial import and predicted to yield a mature peptide of approximately 43.7-KDa. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 8 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF, max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
PP5
Variant 10-123053160-G-A is Pathogenic according to our data. Variant chr10-123053160-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 9199.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr10-123053160-G-A is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ACADSBNM_001609.4 linkuse as main transcriptc.1228G>A p.Gly410Ser missense_variant, splice_region_variant 10/11 ENST00000358776.7 NP_001600.1
ACADSBNM_001330174.3 linkuse as main transcriptc.922G>A p.Gly308Ser missense_variant, splice_region_variant 9/10 NP_001317103.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ACADSBENST00000358776.7 linkuse as main transcriptc.1228G>A p.Gly410Ser missense_variant, splice_region_variant 10/111 NM_001609.4 ENSP00000357873 P1P45954-1
ACADSBENST00000368869.8 linkuse as main transcriptc.922G>A p.Gly308Ser missense_variant, splice_region_variant 9/102 ENSP00000357862 P45954-2
ACADSBENST00000541070.1 linkuse as main transcriptn.400G>A splice_region_variant, non_coding_transcript_exon_variant 1/22

Frequencies

GnomAD3 genomes
AF:
0.0000110
AC:
1
AN:
91058
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000434
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000295
AC:
7
AN:
237360
Hom.:
0
AF XY:
0.0000466
AC XY:
6
AN XY:
128790
show subpopulations
Gnomad AFR exome
AF:
0.0000658
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000214
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000895
AC:
13
AN:
1453070
Hom.:
0
Cov.:
30
AF XY:
0.0000138
AC XY:
10
AN XY:
723346
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000140
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000110
AC:
1
AN:
91058
Hom.:
0
Cov.:
32
AF XY:
0.0000233
AC XY:
1
AN XY:
42932
show subpopulations
Gnomad4 AFR
AF:
0.0000434
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000756
ExAC
AF:
0.0000247
AC:
3

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Deficiency of 2-methylbutyryl-CoA dehydrogenase Pathogenic:2
Pathogenic, no assertion criteria providedliterature onlyOMIMNov 01, 2000- -
Pathogenic, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJun 28, 2023Variant summary: ACADSB c.1228G>A (p.Gly410Ser) results in a non-conservative amino acid change located in the Acyl-CoA dehydrogenase/oxidase C-terminal domain (IPR009075) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. Several computational tools predict a significant impact on normal splicing: Four predict the variant abolishes a canonical 5' splicing donor site. This was confirmed via cDNA sequencing of a homozygous patient, which showed that the variant causes skipping of exon 10 (Andresen_2000). The variant allele was found at a frequency of 2.9e-05 in 237360 control chromosomes (gnomAD). c.1228G>A has been reported in the literature in a Pakistani family with two homozygous individuals affected with Deficiency of 2-methylbutyryl-CoA Dehydrogenase (Andresen_2000). These data indicate that the variant is likely to be associated with disease. Although the variant did not cause absence of the protein through nonsense mediated decay, fibroblasts from a homozygous patient showed less than 10% residual activity when compared to control fibroblasts (Andresen_2000). The following publication have been ascertained in the context of this evaluation (PMID: 11013134). No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.33
BayesDel_addAF
Pathogenic
0.47
D
BayesDel_noAF
Pathogenic
0.44
CADD
Pathogenic
34
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.69
.;D
Eigen
Pathogenic
0.74
Eigen_PC
Pathogenic
0.73
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Pathogenic
0.99
D;D
M_CAP
Uncertain
0.27
D
MetaRNN
Pathogenic
0.81
D;D
MetaSVM
Pathogenic
0.87
D
MutationAssessor
Benign
1.6
.;L
MutationTaster
Benign
1.0
D;D
PrimateAI
Uncertain
0.71
T
PROVEAN
Pathogenic
-5.5
D;D
REVEL
Pathogenic
0.76
Sift
Uncertain
0.026
D;D
Sift4G
Benign
0.14
T;D
Polyphen
1.0
.;D
Vest4
0.66
MutPred
0.47
.;Loss of sheet (P = 0.0817);
MVP
0.97
MPC
0.36
ClinPred
0.69
D
GERP RS
5.3
Varity_R
0.96
gMVP
0.95

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
1.0
SpliceAI score (max)
0.90
Details are displayed if max score is > 0.2
DS_DL_spliceai
0.90
Position offset: 0

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs387906409; hg19: chr10-124812676; API